AbbVie Inc. — trenibotulinumtoxinE (TrenibotE) · Moderate to severe glabellar lines.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (11/6/25) through T+5. Run-up high $236.28 on 12/1/25, low $200.5 on 4/22/26 (T-120 to T-1). FDA decision 4/23/26. Historical price action, not a forecast.